| Jun 6, 2025 |
Oct 24, 2025 |
Bolt Biotherapeutics, Inc.
|
CEO |
Buy |
90.0
|
+40,125
|
1944.98%
|
✗
|
$686.5 |
| Dec 16, 2024 |
May 5, 2025 |
Bolt Biotherapeutics, Inc.
|
CEO |
Buy |
90.0
|
+5,000
|
13.78%
|
✗
|
$2.8K |
| Jun 6, 2023 |
Dec 13, 2023 |
Bolt Biotherapeutics, Inc.
|
CFO |
Buy |
91.3
|
+11,829
|
48.39%
|
✗
|
$11.2K |
| Jun 6, 2022 |
Feb 7, 2023 |
Bolt Biotherapeutics, Inc.
|
CFO |
Buy |
90.0
|
+4,289
|
21.28%
|
✗
|
$6.2K |
| Jun 4, 2021 |
Dec 9, 2021 |
Bolt Biotherapeutics, Inc.
|
CFO |
Buy |
91.3
|
+6,256
|
45.01%
|
✗
|
$44.1K |
| Feb 9, 2021 |
Feb 9, 2021 |
Bolt Biotherapeutics, Inc.
|
CFO |
Buy |
86.3
|
+1,200
|
9.45%
|
✗
|
$24K |
| May 31, 2019 |
Apr 2, 2020 |
Viracta Therapeutics, Inc.
|
Officer |
Buy |
90.0
|
+12,000
|
10.37%
|
✗
|
$6.1K |
| Dec 10, 2018 |
Dec 12, 2018 |
Viracta Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+40,000
|
333.33%
|
✗
|
$18.8K |